CM
SWAV

Crestline Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Crestline Management’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-13,249
Closed -$2.36M – 341
2021
Q4 		$2.36M Buy
+13,249
New +$2.61M 0.18% 107

Other funds holding SWAV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Crestline Management's SWAV Position: Q1 2022 in Review

Crestline Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2022, closing a stake of 13,249 shares — an estimated $2.36M sold.

Crestline Management first reported a position in SWAV in Q4 2021 and held it in 1 quarter. The position peaked at $2.36M in Q4 2021. 308 funds tracked by Wall St. Rank hold SWAV as of Q1 2022.

  • Crestline Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Crestline Management sold 13,249 Shockwave Medical, Inc. Common Stock shares in Q1 2022, an estimated $2.36M.
  • Crestline Management first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Crestline Management's Shockwave Medical, Inc. Common Stock position peaked at $2.36M in Q4 2021.
  • 308 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2022.

Based on Crestline Management's 13F filing for Q1 2022, filed 16 May 2022.